![]() |
|
|
Vol. 289, Issue 3, 1301-1305, June 1999
Department of Pharmacology and Toxicology, Kyorin University School
of Medicine, Mitaka, Tokyo, Japan (M.T., T.S., M.T., S.H.C., Y.K.,
H.E.); and Department of Toxicology, Kyoritsu College of Pharmacy,
Minato-ku, Tokyo, Japan (M.K.)
In the present study, we investigated the transport of
ochratoxin A (OTA) by kidney-specific organic anion transporter 1 (OAT1). When expressed in Xenopus laevis oocytes, OAT1
mediated sodium-independent uptake of OTA
(Km = 2.1 µM). Piroxicam, which has been
shown to prevent the nephrotoxicity of OTA, inhibited OAT1-mediated
uptake of OTA. By contrast, another protective compound, aspartame, did not. Using a cell line derived from the mouse kidney terminal proximal
tubule (S3) transfected with OAT1 cDNA, we investigated the transport
of OTA and also its effect on cell proliferation and cell viability. S3
cells expressing OAT1 mediated the saturable transport of OTA
(Km = 0.57 µM). Cell proliferation was
suppressed in S3 cells expressing OAT1 when exposed to 2 and 10 µM
OTA. This suppression was rescued by the coaddition of 1 mM
p-aminohippurate in the media. The present study
indicates that OTA is transported by OAT1 and that the accumulation of
OTA via OAT1 in proximal tubular cells is the primary event in the
development of OTA nephrotoxicity.
This article has been cited by other articles:
![]() |
G. W. Schnabolk, G. L. Youngblood, and D. H. Sweet Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20) Am J Physiol Renal Physiol, August 1, 2006; 291(2): F314 - F321. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bakhiya, M. Stephani, A. Bahn, B. Ugele, A. Seidel, G. Burckhardt, and H. Glatt Uptake of Chemically Reactive, DNA-Damaging Sulfuric Acid Esters into Renal Cells by Human Organic Anion Transporters J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1414 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. J. Bow, J. L. Perry, J. D. Simon, and J. B. Pritchard The Impact of Plasma Protein Binding on the Renal Transport of Organic Anions J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 349 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marin-Kuan, S. Nestler, C. Verguet, C. Bezencon, D. Piguet, R. Mansourian, J. Holzwarth, M. Grigorov, T. Delatour, P. Mantle, et al. A Toxicogenomics Approach to Identify New Plausible Epigenetic Mechanisms of Ochratoxin A Carcinogenicity in Rat Toxicol. Sci., January 1, 2006; 89(1): 120 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, C. E. Groves, A. Bahn, W. M. Barendt, M. D. Prado, M. Rodiger, V. Chatsudthipong, G. Burckhardt, and S. H. Wright Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubule Am J Physiol Renal Physiol, November 1, 2004; 287(5): F999 - F1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bahn, C. Ebbinghaus, D. Ebbinghaus, E. G. Ponimaskin, L. Fuzesi, G. Burckhardt, and Y. Hagos EXPRESSION STUDIES AND FUNCTIONAL CHARACTERIZATION OF RENAL HUMAN ORGANIC ANION TRANSPORTER 1 ISOFORMS Drug Metab. Dispos., April 1, 2004; 32(4): 424 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Eraly, K. T. Bush, R. V. Sampogna, V. Bhatnagar, and S. K. Nigam The Molecular Pharmacology of Organic Anion Transporters: from DNA to FDA? Mol. Pharmacol., March 1, 2004; 65(3): 479 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama Impact of Drug Transporter Studies on Drug Discovery and Development Pharmacol. Rev., September 1, 2003; 55(3): 425 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Gerk, J. A. Moscow, and P. J. McNamara BASOLATERAL ACTIVE UPTAKE OF NITROFURANTOIN IN THE CIT3 CELL CULTURE MODEL OF LACTATION Drug Metab. Dispos., June 1, 2003; 31(6): 691 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Enomoto, M. Takeda, A. Tojo, T. Sekine, S. H. Cha, S. Khamdang, F. Takayama, I. Aoyama, S. Nakamura, H. Endou, et al. Role of Organic Anion Transporters in the Tubular Transport of Indoxyl Sulfate and the Induction of its Nephrotoxicity J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1711 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O'Brien, A. H. Heussner, and D. R. Dietrich Species-, Sex-, and Cell Type-Specific Effects of Ochratoxin A and B Toxicol. Sci., October 1, 2001; 63(2): 256 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morita, H. Kusuhara, T. Sekine, H. Endou, and Y. Sugiyama Functional Characterization of Rat Organic Anion Transporter 2 in LLC-PK1 Cells J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1179 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Mulato, E. S. Ho, and T. Cihlar Nonsteroidal Anti-Inflammatory Drugs Efficiently Reduce the Transport and Cytotoxicity of Adefovir Mediated by the Human Renal Organic Anion Transporter 1 J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 10 - 15. [Abstract] [Full Text] |
||||
![]() |
S. Wada, M. Tsuda, T. Sekine, S. H. Cha, M. Kimura, Y. Kanai, and H. Endou Rat Multispecific Organic Anion Transporter 1 (rOAT1) Transports Zidovudine, Acyclovir, and Other Antiviral Nucleoside Analogs J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 844 - 849. [Abstract] [Full Text] |
||||
![]() |
R. A. M. H. Van Aubel, R. Masereeuw, and F. G. M. Russel Molecular pharmacology of renal organic anion transporters Am J Physiol Renal Physiol, August 1, 2000; 279(2): F216 - F232. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Cha, T. Sekine, H. Kusuhara, E. Yu, J. Y. Kim, D. K. Kim, Y. Sugiyama, Y. Kanai, and H. Endou Molecular Cloning and Characterization of Multispecific Organic Anion Transporter 4 Expressed in the Placenta J. Biol. Chem., February 11, 2000; 275(6): 4507 - 4512. [Abstract] [Full Text] [PDF] |
||||